156 related articles for article (PubMed ID: 14684850)
41. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
[TBL] [Abstract][Full Text] [Related]
42. Expression analysis of the yersiniabactin receptor gene fyuA and the heme receptor hemR of Yersinia enterocolitica in vitro and in vivo using the reporter genes for green fluorescent protein and luciferase.
Jacobi CA; Gregor S; Rakin A; Heesemann J
Infect Immun; 2001 Dec; 69(12):7772-82. PubMed ID: 11705959
[TBL] [Abstract][Full Text] [Related]
43. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
Zou Z; Zhang W; Young D; Gleave MG; Rennie P; Connell T; Connelly R; Moul J; Srivastava S; Sesterhenn I
Clin Cancer Res; 2002 May; 8(5):1172-7. PubMed ID: 12006534
[TBL] [Abstract][Full Text] [Related]
44. Optical imaging of Renilla luciferase reporter gene expression in living mice.
Bhaumik S; Gambhir SS
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):377-82. PubMed ID: 11752410
[TBL] [Abstract][Full Text] [Related]
45. Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors.
Yang M; Reynoso J; Jiang P; Li L; Moossa AR; Hoffman RM
Cancer Res; 2004 Dec; 64(23):8651-6. PubMed ID: 15574773
[TBL] [Abstract][Full Text] [Related]
46. A Tri-fusion Reporter Mouse Reveals Tissue-Specific FGF1B Promoter Activity in vivo.
Liu SW; Hsu CH; Chen MR; Chiu IM; Lin KM
Sci Rep; 2019 Jul; 9(1):11143. PubMed ID: 31367001
[TBL] [Abstract][Full Text] [Related]
47. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters.
Iyer M; Wu L; Carey M; Wang Y; Smallwood A; Gambhir SS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14595-600. PubMed ID: 11734653
[TBL] [Abstract][Full Text] [Related]
48. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice.
Wu JC; Sundaresan G; Iyer M; Gambhir SS
Mol Ther; 2001 Oct; 4(4):297-306. PubMed ID: 11592831
[TBL] [Abstract][Full Text] [Related]
49. Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology.
Cloutier SM; Chagas JR; Mach JP; Gygi CM; Leisinger HJ; Deperthes D
Eur J Biochem; 2002 Jun; 269(11):2747-54. PubMed ID: 12047384
[TBL] [Abstract][Full Text] [Related]
50. Use of reporter genes for optical measurements of neoplastic disease in vivo.
Contag CH; Jenkins D; Contag PR; Negrin RS
Neoplasia; 2000; 2(1-2):41-52. PubMed ID: 10933067
[TBL] [Abstract][Full Text] [Related]
51. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging.
Choy G; O'Connor S; Diehn FE; Costouros N; Alexander HR; Choyke P; Libutti SK
Biotechniques; 2003 Nov; 35(5):1022-6, 1028-30. PubMed ID: 14628676
[TBL] [Abstract][Full Text] [Related]
52. Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate.
Fang X; Gyabaah K; Nickkholgh B; Cline JM; Balaji KC
Prostate; 2015 Jun; 75(9):988-1000. PubMed ID: 25753731
[TBL] [Abstract][Full Text] [Related]
53. Generation of a highly inducible Gal4-->Fluc universal reporter mouse for in vivo bioluminescence imaging.
Pichler A; Prior JL; Luker GD; Piwnica-Worms D
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15932-7. PubMed ID: 18843112
[TBL] [Abstract][Full Text] [Related]
54. The utility of the "Glowing Head" mouse for breast cancer metastasis research.
Alzubi MA; Boyd DC; Harrell JC
Clin Exp Metastasis; 2020 Apr; 37(2):241-246. PubMed ID: 31938954
[TBL] [Abstract][Full Text] [Related]
55. Dual Modality Imaging of Promoter Activity as a Surrogate for Gene Expression and Function.
Dhadve A; Thakur B; Ray P
Methods Mol Biol; 2018; 1790():1-12. PubMed ID: 29858779
[TBL] [Abstract][Full Text] [Related]
56. Hypoxia-Induced Reporter Genes with Different Half-Lives.
Krishnamachary B; Danhier P; Kakkad S; Bharti SK; Bhujwalla ZM
Methods Mol Biol; 2018; 1790():113-125. PubMed ID: 29858787
[TBL] [Abstract][Full Text] [Related]
57. Whole-Body In Vivo Monitoring of Inflammatory Diseases Exploiting Human Interleukin 6-Luciferase Transgenic Mice.
Hayashi M; Takai J; Yu L; Motohashi H; Moriguchi T; Yamamoto M
Mol Cell Biol; 2015 Oct; 35(20):3590-601. PubMed ID: 26283726
[TBL] [Abstract][Full Text] [Related]
58. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy.
Iyer M; Salazar FB; Lewis X; Zhang L; Wu L; Carey M; Gambhir SS
Transgenic Res; 2005 Feb; 14(1):47-55. PubMed ID: 15865048
[TBL] [Abstract][Full Text] [Related]
59. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer.
Zhang L; Adams JY; Billick E; Ilagan R; Iyer M; Le K; Smallwood A; Gambhir SS; Carey M; Wu L
Mol Ther; 2002 Mar; 5(3):223-32. PubMed ID: 11863411
[TBL] [Abstract][Full Text] [Related]
60. Constraints to counting bioluminescence producing cells by a commonly used transgene promoter and its implications for experimental design.
Mosaad EO; Futrega K; Seim I; Gloss B; Chambers KF; Clements JA; Doran MR
Sci Rep; 2019 Aug; 9(1):11334. PubMed ID: 31383876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
